LGMD2A clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 12-50
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
Orange, California and other locations
Our lead scientists for LGMD2A research studies include Tahseen Mozaffar, MD.